Study of the density of Demodex mite in patients with topical steroid damage

Vishakha Malviya; C. Namdeo; K. Bhatia; Sunayana Kushwah

doi:10.18203/issn.2455-4529.IntJResDermatol20253395

Authors

Vishakha Malviya Department of Dermatology, RD Gardi Medical College, Ujjain, Madhya Pradesh, India
C. Namdeo Department of Dermatology, Sri Aurobindo Medical College and PGI, Indore, Madhya Pradesh, India
K. Bhatia Department of Dermatology, Sri Aurobindo Medical College and PGI, Indore, Madhya Pradesh, India
Sunayana Kushwah Department of Dermatology, AIIMS, Bhuvneshwar, Odisha,

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20253395

Keywords:

Demodex mites, Demodicosis, Topical steroids, Topical steroid damaged face, Steroid misuse

Abstract

Background: There is a possible association between the usage of topical steroids on the face and the density of Demodex mites. This study was undertaken with the aim to study the density of Demodex mites in patients with topical steroid-damaged faces.

Methods: This cohort study included 232 patients with TSDF (group A) and 40 patients with no facial dermatological lesions and conditions and with no history of use of topical steroids (group B). The sample from the skin was collected using the skin surface biopsy (SSB) technique with cyanoacrylic glue and skin tape stripping (STS) method.

Results: There was a significantly greater density of Demodex mites amongst group A subjects compared to group B subjects [18.5% vs 5.0%] (p value <.05). There was no statistically significant association between the duration and potency of TC use and the density of Demodex mites (p value >0.05). Clinical features were also not found to have a significant association with the potency of TC used.

Conclusions: Infestation of facial skin with Demodex mites is significantly associated with the use of topical steroids on the face. There was no statistically significant association between the duration and potency of TC use and the density of Demodex mites.

Metrics

Metrics Loading ...

References

Elston CA & Elston DM. Demodex mites. Clin Dermatol. 2014;32(6):739-43. DOI: https://doi.org/10.1016/j.clindermatol.2014.02.012

Rather PA, Hassan I. Human demodex mite: the versatile mite of dermatological importance. Ind J Dermatol. 2014;59(1):60-66. DOI: https://doi.org/10.4103/0019-5154.123498

Clity E, Sayavong K and Chanthavisouk K. Demodecidosis in apatient infected by HIV: successful treatment with ivermectin. Ann Dermatol Venereol. 2005;132(5):459-61. DOI: https://doi.org/10.1016/S0151-9638(05)79308-X

Wesołowska M, Baran W, Szepietowski J, Hirschberg L, Jankowski S. Demodekoza u ludzi jako aktualny problem w dermatologii [Demodicidosis in humans as a current problem in dermatology]. Wiad Parazytol. 2005;51(3):253-6.

Guerrero-González GA, Herz-Ruelas ME, Gómez-Flores M, Ocampo-Candiani J. Crusted demodicosis in an immunocompetent pediatric patient. Case Rep Dermatol Med. 2014;2014:458046. DOI: https://doi.org/10.1155/2014/458046

Seyhan ME, Karincaoglu Y, Bayram N, Aycan O, Kuku I. Density of Demodex folliculorum in haematological malignancies. J Inter Med Res. 2004;32:411-5. DOI: https://doi.org/10.1177/147323000403200410

Sethi S, Chauhan P, Jindal R, Bisht YS. Dermoscopy of topical steroid-dependent or damaged face: A cross-sectional study. Ind J Dermatol Venereol Leprol. 2021;88(1):40-6. DOI: https://doi.org/10.25259/IJDVL_11_2020

Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Ind J Dermatol Venereol Leprol. 2011;77(2):160-6. DOI: https://doi.org/10.4103/0378-6323.77455

Takeda K, Arase S, Takahashi S. Side effects of topical corticosteroids and their prevention. Drugs. 1988;36(Suppl 5):15-23. DOI: https://doi.org/10.2165/00003495-198800365-00005

Lahiri K and Coondo K. Topical steroid damaged/dependent face (TDSF): An entity of cutaneous pharmaco-dependence. Ind J Dermatol. 2016;61:265-272. DOI: https://doi.org/10.4103/0019-5154.182417

Dolenc-Voljc M, Pohar M, Lunder T. Density of Demodex folliculorum in perioral dermatitis. Acta Derm Venereol. 2005;85(3):211-5. DOI: https://doi.org/10.1080/00015550510030069

Keles H, Pancar Yuksel E, Aydin F, Senturk N. Pre-Treatment and Post-Treatment Demodex Densities in Patients under Immunosuppressive Treatments. Medicina (Kaunas). 2020;56(3):107. DOI: https://doi.org/10.3390/medicina56030107

Jain S, Mohapatra L, Mohanty P, Jena S, Behera B. Study of clinical profile of patients presenting with topical steroid-induced facial dermatosis to a tertiary care hospital. Ind Dermatol Online J. 2020;11(2):208-11. DOI: https://doi.org/10.4103/idoj.IDOJ_259_19

Stacey SK, McEleney M. Topical Corticosteroids: Choice and Application. Am Fam Physician. 2021;103(6):337-43.

Abraham A, Roga G. Topical steroid damaged skin. Indian J Dermatol. 2014;59:456-9. DOI: https://doi.org/10.4103/0019-5154.139872

Forton F, Seys B, Marchal JL, Song M. Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy. The Brit J Dermatol. 1998;138(3):461-6. DOI: https://doi.org/10.1046/j.1365-2133.1998.02125.x

Olesen CM, Fuchs CS, Philipsen PA, Hædersdal M, Agner T, Clausen ML. Advancement through epidermis using tape stripping technique and Reflectance Confocal Microscopy. Sci Rep. 2019;9(1):12217. DOI: https://doi.org/10.1038/s41598-019-48698-w

Al Dhafiri M, Alali AB, Alghanem ZA, Alsaleh ZW, Boushel EA, Alali ZB, et al. Topical steroid damaged face: a cross-sectional study from Saudi Arabia. Clin Pract. 2022;12(1):140-6. DOI: https://doi.org/10.3390/clinpract12010018

Pal D, Biswas P, Das S, De A, Sharma N, Ansari A. Topical steroid damaged/dependent face (TSDF): A study from a tertiary care hospital in Eastern India. Ind J Dermatol. 2018;63(5):375-9. DOI: https://doi.org/10.4103/ijd.IJD_218_17

Srivastava M, Balasubramanian P, Anil AJ. A study of topical steroid induced facial dermatosis in Andaman and Nicobar Islands and to analyse the role of Demodex mite in its pathogenicity. Int J Res. 2019;5(1):67. DOI: https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20185508

Hameed AF. Steroid dermatitis resembling rosacea: a clinical evaluation of 75 patients. ISRN Dermatol. 2013;2013:491376. DOI: https://doi.org/10.1155/2013/491376

Ramshida AP, Manikandan K. Cosmetics usage and its relation to sex, age and marital status. Int J Soci Sci Interdisci Res. 2014;3(3):46-55.

Dey VK. Misuse of topical corticosteroids: A clinical study of adverse effects. Ind Dermatol Online J. 2014;5(4):436-40. DOI: https://doi.org/10.4103/2229-5178.142486

Hibbert D, Bissell P, Ward PR. Consumerism and professional work in the community pharmacy. Sociol Health Illness 2002;24:46-65. DOI: https://doi.org/10.1111/1467-9566.00003

Gray N, Cantrill J, Noyce PR. Mass media health information available to young adults in the United Kingdom. Int J Pharm Pract. 1998;6:180-95. DOI: https://doi.org/10.1111/j.2042-7174.1998.tb00936.x

Rapaport MJ, Rapaport VH. Serum nitric oxide levels in “red” patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch Dermatol. 2004;140(8):1013-4. DOI: https://doi.org/10.1001/archderm.140.8.1013

Erbagˇci Z, Özgöztaşi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol. 1998;37(6):421-5. DOI: https://doi.org/10.1046/j.1365-4362.1998.00218.x

Zhao YE, Guo N, Xun M, Xu JR, Wang M, Wang DL. Sociodemographic characteristics and risk factor analysis of Demodex infestation (Acari: Demodicidae). J. Zhejiang Univ Sci. 2011;12:998-1007. DOI: https://doi.org/10.1631/jzus.B1100079